Type to search

VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Amplifying RNA Platform | Pharmtech Focus
Pfizer and Biontech Expand Collaboration with U.S. To Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries | Pharmtech Focus
Naobios Manufactures FluGen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials | Pharmtech Focus